Top Stories
Top Stories
Wires

ABBVIE'S ALLERGAN TAKEOVER, WORTH $188 A SHARE IN CASH AND STOCK, IS EXPECTED TO BE ANNOUNCED LATER TUESDAY - WSJ, CITING SOURCES